XML 45 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2
Earnings per Share (Tables)
 9 Months Ended
Jun. 30, 2016
Earnings Per Share [Abstract]  
Net components of basic and diluted earnings per share
Components of basic and diluted (loss) earnings per share and excluded anti-dilutive potential common shares are as follows: 
 
Three Months Ended June 30,
 
Nine Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
 
 
 
 
 
 
 
 
 
(in thousands, except per share amounts)
Net income (loss) from continuing operations attributable to EZCORP (A)
$
2,904

 
$
(683
)
 
$
8,954

 
$
5,807

Loss from discontinued operations, net of tax (B)
(8,593
)
 
(9,164
)
 
(96,242
)
 
(2,699
)
Net (loss) income attributable to EZCORP (C)
$
(5,689
)
 
$
(9,847
)
 
$
(87,288
)
 
$
3,108

 
 
 
 
 
 
 
 
Weighted-average outstanding shares of common stock (D)
53,980

 
54,820

 
54,574

 
54,216

Dilutive effect of restricted stock*
212

 
—

 
116

 
64

Weighted-average common stock and common stock equivalents (E)
54,192


54,820


54,690


54,280

 
 
 
 
 
 
 
 
Basic (loss) earnings per share attributable to EZCORP:
 
 
 
 
 
 
 
Continuing operations (A / D)
$
0.05

 
$
(0.01
)
 
$
0.16

 
$
0.11

Discontinued operations (B / D)
(0.16
)
 
(0.16
)
 
(1.76
)
 
(0.06
)
Basic (loss) earnings per share (C / D)
$
(0.11
)
 
$
(0.17
)
 
$
(1.60
)
 
$
0.05

 
 
 
 
 
 
 
 
Diluted (loss) earnings per share attributable to EZCORP:
 
 
 
 
 
 
 
Continuing operations (A / E)
$
0.05

 
$
(0.01
)
 
$
0.16

 
$
0.11

Discontinued operations (B / E)
(0.16
)
 
(0.16
)
 
(1.76
)
 
(0.06
)
Diluted (loss) earnings per share (C / E)
$
(0.11
)
 
$
(0.17
)
 
$
(1.60
)
 
$
0.05

 
 
 
 
 
 
 
 
Potential unweighted common shares excluded from the calculation of diluted (loss) earnings per share above:
 
 
 
 
 
 
 
Restricted stock**
2,109

 
428

 
1,259

 
—

Warrants***
14,317

 
14,317

 
14,317

 
14,317

Total potential common shares excluded
16,426

 
14,745

 
15,576

 
14,317


*
As required by FASB ASC 260-10-45-19, amount excludes all potential common shares for periods when there is a loss from continuing operations.
**
Includes antidilutive share-based awards as well as performance-based and market conditioned share-based awards that are contingently issuable, but for which the condition for issuance has not been met as of the end of the reporting period.
***
See Note 7 for discussion of the terms and conditions of these potential common shares.